These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 31303349

  • 1. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W, Tighiouart H, Ku E, Salem D, Sarnak MJ.
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [Abstract] [Full Text] [Related]

  • 2. Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
    McCallum W, Tighiouart H, Ku E, Salem D, Sarnak MJ.
    Kidney Int; 2019 Nov; 96(5):1185-1194. PubMed ID: 31420191
    [Abstract] [Full Text] [Related]

  • 3. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J.
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [Abstract] [Full Text] [Related]

  • 4. Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ishigami J, Kansal M, Mehta R, Srivastava A, Rahman M, Dobre M, Al-Kindi SG, Go AS, Navaneethan SD, Chen J, He J, Bhat ZY, Jaar BG, Appel LJ, Matsushita K, CRIC Study Investigators.
    Am J Kidney Dis; 2023 Aug; 82(2):225-236. PubMed ID: 36935072
    [Abstract] [Full Text] [Related]

  • 5. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R, Gabbai FB, Chiodini P, Provenzano M, Borrelli S, Garofalo C, Bellizzi V, Russo D, Conte G, De Nicola L, Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology.
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [Abstract] [Full Text] [Related]

  • 6. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
    [Abstract] [Full Text] [Related]

  • 7. Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.
    Bowling CB, Sanders PW, Allman RM, Rogers WJ, Patel K, Aban IB, Rich MW, Pitt B, White M, Bakris GC, Fonarow GC, Ahmed A.
    Int J Cardiol; 2013 Jul 15; 167(1):151-6. PubMed ID: 22257685
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
    Xu X, Qin X, Li Y, Sun D, Wang J, Liang M, Wang B, Huo Y, Hou FF, investigators of the Renal Substudy of the China Stroke Primary Prevention Trial (CSPPT).
    JAMA Intern Med; 2016 Oct 01; 176(10):1443-1450. PubMed ID: 27548766
    [Abstract] [Full Text] [Related]

  • 9. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1993 Nov 01; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [Abstract] [Full Text] [Related]

  • 10. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May 01; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

  • 11. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
    Beldhuis IE, Streng KW, Ter Maaten JM, Voors AA, van der Meer P, Rossignol P, McMurray JJ, Damman K.
    Circ Heart Fail; 2017 Feb 01; 10(2):. PubMed ID: 28209765
    [Abstract] [Full Text] [Related]

  • 12. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul 01; 50(7):1297-300. PubMed ID: 12133029
    [Abstract] [Full Text] [Related]

  • 13. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A, van der Giet M, Kuhlmann MK, Martus P, Mielke N, Ebert N, Schaeffner ES.
    Am J Kidney Dis; 2021 Mar 01; 77(3):386-396.e1. PubMed ID: 33197533
    [Abstract] [Full Text] [Related]

  • 14. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
    Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y, FEATHER Study Investigators.
    Am J Kidney Dis; 2018 Dec 01; 72(6):798-810. PubMed ID: 30177485
    [Abstract] [Full Text] [Related]

  • 15. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL, Jongs N, Chertow GM, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Stefansson BV, Toto RD, Wheeler DC, Greene T, DAPA-CKD Trial Committees and Investigators.
    Lancet Diabetes Endocrinol; 2021 Nov 01; 9(11):743-754. PubMed ID: 34619108
    [Abstract] [Full Text] [Related]

  • 16. Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.
    Zelnick LR, Katz R, Young BA, Correa A, Kestenbaum BR, de Boer IH, Bansal N.
    Am J Kidney Dis; 2017 Aug 01; 70(2):199-206. PubMed ID: 28143672
    [Abstract] [Full Text] [Related]

  • 17. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
    Lam PH, Dooley DJ, Fonarow GC, Butler J, Bhatt DL, Filippatos GS, Deedwania P, Forman DE, White M, Fletcher RD, Arundel C, Blackman MR, Adamopoulos C, Kanonidis IE, Aban IB, Patel K, Aronow WS, Allman RM, Anker SD, Pitt B, Ahmed A.
    Eur J Heart Fail; 2018 Feb 01; 20(2):359-369. PubMed ID: 28980368
    [Abstract] [Full Text] [Related]

  • 18. Effect of Vitamin B12 Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial.
    Li Y, Spence JD, Wang X, Huo Y, Xu X, Qin X.
    Am J Kidney Dis; 2020 Mar 01; 75(3):325-332. PubMed ID: 31629573
    [Abstract] [Full Text] [Related]

  • 19. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul 01; 50(7):1293-6. PubMed ID: 12133028
    [Abstract] [Full Text] [Related]

  • 20. Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.
    Xie Y, Bowe B, Xian H, Balasubramanian S, Al-Aly Z.
    Am J Kidney Dis; 2016 Aug 01; 68(2):219-228. PubMed ID: 26948835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.